Author

Bruno Da Costa

Université de Versailles Saint-Quentin-en-Yvelines

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Adeline CezardiD· 1 shared Alan WacquieziD· 1 shared Ambre TinardiD· 1 shared Antoine GuilloniD· 1 shared Antoine LegrasiD· 1 shared Arnaud MachelartiD· 1 shared Christophe PagetiD· 1 shared Cyrille MathieuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adeline CezardORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling

Adeline Cezard, Déborah Bréa, Virginie Vasseur, Alan Wacquiez, Loïc Gonzalez, Ronan Le Goffic, Bruno Da Costa, Ambre Tinard, Delphine Fouquenet, Séverine Heumel, Arnaud Machelart, Eik Hoffmann, Priscille M Brodin, François Trottein, Cyrille Mathieu, , Mustapha Si‐Tahar

This study identifies cis-aconitate as a dual-action antiviral and anti-inflammatory agent that reduces influenza mortality in mice by targeting viral polymerase and ERK/AKT/NF-κB signaling.

EMBO Molecular Medicine · Feb 16, 2026Peer-reviewedImmunology